Pre-earnings options volume in Trevi Therapeutics (TRVI) is 2.8x normal with calls leading puts 12:1. Implied volatility suggests the market is anticipating a move near 7.8%, or 0c, after results are released. Median move over the past eight quarters is 2.7%.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRVI:
- Trevi Therapeutics added to Analyst Current Favorites list at Raymond James
- Trevi Therapeutics: Buy Rating Amid Promising Haduvio Trial Prospects and Strong Market Potential
- Trevi Therapeutics (TRVI) Q4 Earnings Cheat Sheet
- Largest borrow rate increases among liquid names
- Biotech Alert: Searches spiking for these stocks today
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue